ClassID:

20662

A61K35/66 - CPC Classification

Classification description:

Medicinal preparations containing materials or reaction products thereof with undetermined constitution Microorganisms or materials therefrom

Sub-classes:
Recent Application in this class:
#1
20260061014
2026-03-05

METHOD FOR LOSING WEIGHT AND REDUCING PRODUCTION OF ADVANCED GLYCATION END PRODUCTS BY USING SACCHAROMYCES CEREVISIAE TCI907 AND/OR SUPERNATANT THEREOF

#2
20250171749
2025-05-29

GENETICALLY MODIFIED ORGANISMS FOR PRODUCING PSYCHOTROPIC ALKALOIDS

#3
20250075168
2025-03-06

METHOD FOR REGULATING BLOOD GLUCOSE, LOSING WEIGHT, AND REDUCING PRODUCTION OF ADVANCED GLYCATION END PRODUCTS BY USING SACCHAROMYCES CEREVISIAE TCI907 AND/OR METABOLITE THEREOF

#4
20250011710
2025-01-09

DRIED MICROORGANISM WITH EXCIPIENT

#5
20240316120
2024-09-26

MICROBIAL COMPOSITIONS COMPRISING RUMEN MICROFLORA AND USES THEREOF

#6
20240279308
2024-08-22

TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

#7
20240180850
2024-06-06

COMPOSITIONS AND METHODS FOR FABRICATING DEGRADABLE FLOCKED OBJECTS

#8
20240150798
2024-05-09

MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE

#9
20240110216
2024-04-04

Production of Activated TDP-Deoxysugars in Recombinant Microorganisms

#10
20240101976
2024-03-28

Genetically modified organisms for producing psychotropic alkaloids

#11
20240041944
2024-02-08

OPTIMIZED INDIVIDUALIZED PREBIOTIC COMPOSITIONS

#12
20240009262
2024-01-11

CLEANSING PAD AND COMPOSITION FOR REDUCING TOXINS

#13
20230399688
2023-12-14

COMPOSITIONS AND MULTIPLEXED SYSTEMS FOR COUPLED CELL-FREE TRANSCRIPTION-TRANSLATION AND PROTEIN SYNTHESIS AND METHODS FOR USING THEM

#14
20230390449
2023-12-07

THERAPEUTIC COMPOSITIONS FOR ENHANCED HEALING OF WOUNDS AND SCARS

#15
20230383331
2023-11-30

METHODS AND MATERIALS FOR ASSESSING AND TREATING ARTHRITIS

#16
20230355751
2023-11-09

COMPOSITIONS AND METHODS FOR A MULTI-ADJUVANT ONLY APPROACH TO IMMUNOPROPHYLAXIS FOR PREVENTING INFECTIONS

#17
20230227530
2023-07-20

T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

#18
20220241194
2022-08-04

CROSSLINKABLE HYDROGEL COMPOSITIONS

#19
20220202933
2022-06-30

Method of treating, reducing, or alleviating a medical condition in a patient

#20
20220184148
2022-06-16

MICROBIOME RESPONSE TO AGENTS

#21
20220168227
2022-06-02

Method for producing hydrogel microcapsules, kit for producing capsules, and use therefor

#22
20220119381
2022-04-21

Composition for inhibiting growth of SARS-CoV-2 and method of preparing the same

#23
20210322488
2021-10-21

Treatment Methodology for the Prevention and Control of Viral Infections

#24
20210261912
2021-08-26

METHOD FOR PREPARING COMPOSITION COMPRISING KILLED OR INACTIVATED METHANOBREVIBACTER ARCHAEBACTERIA CELLS AND COMPOSITION THEREBY OBTAINED

#25
20210230660
2021-07-29

CAROTENOIDS FOR TREATING OR PREVENTING NAUSEA

#26
20210128641
2021-05-06

COMPOSITIONS AND METHODS FOR TREATING SKIN AND MUCOUS MEMBRANE DISEASES

#27
20210121597
2021-04-29

Therapeutic compositions for enhanced healing of wounds and scars

#28
20210101956
2021-04-08

Transfected T-cells and T-cell receptors for use in immunotherapy against cancers

#29
20210053909
2021-02-25

Antimicrobial compound and use thereof

#30
20210047701
2021-02-18

SACCHAROMYCES CEREVISIAE TCI907, COMPOSITION AND USE OF SACCHAROMYCES CEREVISIAE TCI907, AND/OR ITS METABOLITES

#31
20200353075
2020-11-12

Compositions and methods for a multi-adjuvant only approach to immunoprophylaxis for preventing infections

#32
20200352851
2020-11-12

METHOD OF TREATING AN EYE DISORDER BY INHIBITING OR DISRUPTING BACTERIAL BIOFILM FORMATION

#33
20200339652
2020-10-29

Transfected T-cells and T-cell receptors for use in immunotherapy against cancers

#34
20200323933
2020-10-15

Echovirus for treatment of tumors

#35
20200316175
2020-10-08

Nutritional composition for treating or preventing impaired mobility

#36
20200255882
2020-08-13

Carotenoids for treating or preventing nausea

#37
20200163341
2020-05-28

Method and composition comprising detoxified lipopolysaccharide and lipoteichoic acid for preventing or inhibiting formation of biofilm

#38
20200155595
2020-05-21

Clay product and uses thereof

#39
20200087701
2020-03-19

Methods and materials for assessing and treating arthritis

#40
20200069749
2020-03-05

LACTOBACILLUS-BASED ECOLI INHIBITION

#41
20200040067
2020-02-06

ANTI-SALMONELLA ANTIBODIES AND USES THEREOF

#42
20190338239
2019-11-07

DRIED MICROORGANISM WITH EXCIPIENT

#43
20190328797
2019-10-31

Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient

#44
20190309042
2019-10-10

Transfected T-cells and T-cell receptors for use in immunotherapy against cancers

#45
20190300972
2019-10-03

sp. strain having prophylactic or therapeutic effects on degenerative brain diseases and use thereof

#46
20190192583
2019-06-27

Drugs (variants) and methods for restoring microflora

#47
20190167769
2019-06-06

Feed additive composition

#48
20190167734
2019-06-06

Pharmaceutical composition and methods for the prevention and/or treatment of using artificial bacterial colonization

#49
20190160114
2019-05-30

OPTIMIZED INDIVIDUALIZED PREBIOTIC COMPOSITIONS

#50
20190106463
2019-04-11

Engineered polypeptides for antigen delivery

#51
20190091142
2019-03-28

Method of treating an eye disorder by inhibiting or disrupting bacterial biofilm formation

#52
20190022152
2019-01-24

MICROBIOME RESPONSE TO AGENTS

#53
20180355014
2018-12-13

Modified chimeric receptors and related compositions and methods

#54
20180325967
2018-11-15

Stable dry compositions having no or little sugars

#55
20180296481
2018-10-18

Infant formula with special lipid architecture for promoting healthy growth

#56
20180245118
2018-08-30

Production of activated TDP-deoxysugars in recombinant microorganisms

#57
20180237847
2018-08-23

COMPOSITIONS AND MULTIPLEXED SYSTEMS FOR COUPLED CELL-FREE TRANSCRIPTION-TRANSLATION AND PROTEIN SYNTHESIS AND METHODS FOR USING THEM

#58
20180207165
2018-07-26

METHODS AND COMPOSITIONS FOR STIMULATING BENEFICIAL BACTERIA IN THE GASTROINTESTINAL TRACT

#59
20180193390
2018-07-12

Bioactive animal feed

#60
20180171282
2018-06-21

mycelium active substances, preparation method, pharmaceutical composition and application thereof

#61
20180078619
2018-03-22

Antibacterial composition for combating carbapenem-resistant gram-negative bacteria comprising ADK protein as active ingredient

#62
20180030120
2018-02-01

Anti-salmonella antibodies and uses thereof

#63
20180021452
2018-01-25

Bacterium-contained hydrogel and method of making the same

#64
20170333514
2017-11-23

Probiotic fermented cereal compositions and methods for treatment of gastrointestinal diseases caused by pro-inflammatory bacteria

#65
20170333492
2017-11-23

Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient

#66
20170326071
2017-11-16

YEAST CELL WALL PARTICLES FOR RECEPTOR-TARGETED NANOPARTICLE DELIVERY

#67
20170303561
2017-10-26

Method for producing biomass which has a high exopolysaccharide content

#68
20170232057
2017-08-17

Opioid peptide

#69
20170136260
2017-05-18

BEVERAGE MADE UP OF THERAPEUTIC AGENTS IN COMBINATION WITH A TRANSPARENT CAN THAT CAN BE LIT UP

#70
20170065647
2017-03-09

COMPOSITIONS AND METHODS FOR TREATING SKIN AND MUCOUS MEMBRANE DISEASES

#71
20160312176
2016-10-27

CORDYCEPS CICADAE MYCELIUM ACTIVE SUBSTANCES, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

#72
20160265016
2016-09-15

ARCHAEA AND LIPID COMPOSITIONS OBTAINED THEREFROM

#73
20160220609
2016-08-04

REGULATION OF STEROIDOGENIC ACTIVITY BY USING PURIFIED SHILAJIT

#74
20160213755
2016-07-28

Feed additive composition

#75
20160213644
2016-07-28

Regulation of body weight gain by using dibenzo-alpha-pyrones

#76
20160175251
2016-06-23

Yeast cell wall particles for receptor-targeted nanoparticle delivery

#77
20160108442
2016-04-21

Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate

#78
20160095323
2016-04-07

Chromobacterium bioactive compositions and metabolites

#79
20160015757
2016-01-21

Microbial compositions comprising rumen microflora and uses thereof

#80
20150352160
2015-12-10

Therapeutic compositions and methods for treating infections

#81
20150283276
2015-10-08

Method for Controlling Fungal Plant Pathogens Using a Combination of UV Radiation Followed by Antagonist Application and Dark Period

#82
20150209392
2015-07-30

Filaments Comprising a Microorganism and Method for Making Same

#83
20150174180
2015-06-25

Selecting, producing, and feeding whole algae as a feed supplement for cattle and bison to produce meat high in omega 3'S for human health

#84
20150150784
2015-06-04

DERMATOLOGICAL COMPOSITION CONTAINING CULTURED THEOBROMA CACAO CELLS OR ITS EXTRACTS AND RELATED METHODS

#85
20150141901
2015-05-21

LOW-LEVEL LASER IRRADIATION OF STIMULATED HUMAN STEM CELLS

#86
20150023922
2015-01-22

Methods for promoting neuronal development and/or health

#87
20140322261
2014-10-30

Use of cell wall disrupted product of chlorella for reducing serum resistin level

#88
20140227319
2014-08-14

Selecting, producing, and feeding whole algae as a feed supplement for cattle and bison to produce meat high in omega 3's for human health

#89
20140199269
2014-07-17

Chromobacterium bioactive compositions and metabolites

#90
20140147509
2014-05-29

Microorganism comprising particles and uses of same

#91
20140099373
2014-04-10

Clay product and uses thereof

#92
20140093554
2014-04-03

NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE

#93
20140037582
2014-02-06

Feed additive composition

#94
20130295079
2013-11-07

Pharmaceutical composition for strengthening spleen and stomach and preparation method therefor

#95
20130287740
2013-10-31

COMPOSITIONS FOR PREPARING A COFFEE BEVERAGE COMPRISING HYDROLYSED CHLOROGENIC ACID

#96
20130251698
2013-09-26

COMPOSITION AND METHOD FOR AFFECTING CYTOKINES AND NF-KB

#97
20130209404
2013-08-15

Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors

#98
20130195821
2013-08-01

Probiotic fermented cereal compositions and methods for treatment of gastrointestinal diseases caused by pro-inflammatory bacteria

#99
20130177577
2013-07-11

NLRC5 AS A TARGET TO INTERVENE MHC CLASS 1-MEDIATED IMMUNE RESPONSES

#100
20130071366
2013-03-21

Insulin-like growth factor II (IGF-II) binding factors

#101
20120269791
2012-10-25

Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors

#102
20120100236
2012-04-26

bioactive compositions and metabolites

#103
20120070376
2012-03-22

Yeast cell wall particles for receptor-targeted nanoparticle delivery

#104
20110300225
2011-12-08

Nutritional compositions with coated lipid globules

#105
20110300204
2011-12-08

NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE

#106
20110229930
2011-09-22

Microorganism comprising particles and uses of same

#107
20110189132
2011-08-04

Microbial product containing multiple microorganisms

#108
20110044951
2011-02-24

Compositions for preparing a coffee beverage comprising hydrolysed chlorogenic acid

#109
20100189812
2010-07-29

AGENT FOR TREATING AND/OR PREVENTING OSTEOPOROSIS, COMPRISING OCEANIC MINERAL COMPONENTS

#110
20090304651
2009-12-10

Insulin-like growth factor II (IGF-II) binding factors

#111
20090108066
2009-04-30

OPTICAL SYSTEM FOR BARCODE SCANNER

#112
20080311097
2008-12-18

Treatment of Ibd and Ibs Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors

#113
20080220028
2008-09-11

ARCHAEAL POLAR LIPID AGGREGATES FOR ADMINISTRATION TO ANIMALS